ISSN Approved Journal || eISSN: 2582-8185 || CODEN: IJSRO2 || Impact Factor 8.2 || Google Scholar and CrossRef Indexed
Fast Publication within 48 hours || Low Article Processing Charges || Peer Reviewed and Referred Journal || Free Certificate
Comparative evaluation on the effect of selected ergot-derived dopamine on some female reproductive hormones in Wistar rats
1 Department of Biochemistry, Faculty of Science, Rivers State University, Nigeria.
2 Department of Pharmacology, Faculty of Basic Clinical Science, College of Medical Sciences, Rivers State University, Nigeria.
3 Department of Community Medicine, Faculty of Clinical Sciences, College of Medical Sciences, Rivers State University, Nigeria. .
4 Department of Physiology, Faculty of Basic Clinical Science, College of Medical Sciences, Rivers State University, Nigeria.
Research Article
International Journal of Science and Research Archive, 2022, 05(01), 103–107.
Article DOI: 10.30574/ijsra.2022.5.1.0043
Publication history:
Received on 09 January 2022; revised on 14 February 2022; accepted on 16 February 2022
Abstract:
Background: Hormonal imbalance can occur during some disease conditions, while in some other cases, an increase or decrease in the levels of the female hormones in the body might be associated with adverse effects from drugs and may also pose the risk of infertility and Ovarian cancers when these drugs are abused. Although the dopamine agonists have been helpful in ameliorating some disease conditions, it could also cause an adverse effect on the reproductive hormones and other organs of the body.
Objective: This study comparatively evaluated the effect of Bromocriptine and Cabergoline on some female reproductive hormones.
Methodology: This study was carried out using twenty-five rats grouped into five groups of five rats in each. Group one was the control group, Group 2 and 3 were low and high dose of Bromocriptine, while Group 4 and 5 were low and high dose Cabergoline. The drugs were administered twenty-four hourly and lasted for 21 days. Blood samples were collected for hormonal assay.
Results: The results for the bioassay of FSH, LH, PROG, PRO and Estrogen revealed that both low and high dose of Bromocriptine and Cabergoline administered to the Wistar rats caused an increase in the concentration of FSH, LH, Progesterone, Prolactin and Estrogen. The level of Prolactin and Estrogen increased significantly at 0.05 level. However, a decrease was observed in prolactin and estrogen level when administered High dose bromocriptine and Low dose cabergoline respectively.
Conclusion: This assessment therefore suggests that both Cabergoline and Bromocriptine had no adverse effects on the female reproductive hormones, however, Cabergoline may pose greater effectiveness than bromocriptine, hence adherence to prescription is necessary for effectiveness.
Keywords:
Bromocriptine; Cabergoline; FSH: Follicle stimulating hormone; LH: Luteinizing hormone; PROG: Progesterone; PRO: Prolactin; E: Estrogen
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
